HK1222849A1 - 具有作爲 抑制劑的活性的取代的三唑並吡啶類 - Google Patents
具有作爲 抑制劑的活性的取代的三唑並吡啶類Info
- Publication number
- HK1222849A1 HK1222849A1 HK16111004.3A HK16111004A HK1222849A1 HK 1222849 A1 HK1222849 A1 HK 1222849A1 HK 16111004 A HK16111004 A HK 16111004A HK 1222849 A1 HK1222849 A1 HK 1222849A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- mps
- inhibitors
- activity
- substituted triazolopyridines
- triazolopyridines
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 150000008523 triazolopyridines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13170978 | 2013-06-07 | ||
EP13186298 | 2013-09-27 | ||
PCT/EP2014/061416 WO2014195276A1 (en) | 2013-06-07 | 2014-06-03 | Substituted triazolopyridines having activity as mps-1 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1222849A1 true HK1222849A1 (zh) | 2017-07-14 |
Family
ID=50877309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16111004.3A HK1222849A1 (zh) | 2013-06-07 | 2016-09-20 | 具有作爲 抑制劑的活性的取代的三唑並吡啶類 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20160264568A1 (zh) |
EP (1) | EP3004093A1 (zh) |
JP (1) | JP2016527193A (zh) |
CN (1) | CN105431435A (zh) |
CA (1) | CA2914521A1 (zh) |
HK (1) | HK1222849A1 (zh) |
WO (1) | WO2014195276A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS56034B1 (sr) * | 2013-06-11 | 2017-09-29 | Bayer Pharma AG | Derivati prolekova supstituisanih triazolopiridina |
CN107567503B (zh) | 2015-04-17 | 2022-03-22 | 荷兰转化研究中心有限责任公司 | 用于ttk抑制剂化疗的预后生物标记 |
EP3956330A4 (en) | 2019-04-18 | 2023-01-18 | The Johns Hopkins University | SUBSTITUTED 2-AMINO-PYRAZOLYL-[1,2,4]TRIAZOLO[1,5A]PYRIDINE DERIVATIVES AND THEIR USE |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57144234A (en) * | 1981-03-03 | 1982-09-06 | Sagami Chem Res Center | 1-halophenyl-2-oxy-1-alkanone acetal |
US4533734A (en) * | 1983-11-10 | 1985-08-06 | Eli Lilly And Company | Inotropic agents |
US7105544B2 (en) * | 2001-07-05 | 2006-09-12 | Synaptic Pharmaceutical Corporation | Substituted alkyl amido piperidines |
DK2054418T3 (da) * | 2006-07-06 | 2012-02-27 | Array Biopharma Inc | Dihydrothieno-pyrimidiner som AKT-proteinkinase-inhibitorer |
JO3598B1 (ar) * | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني |
TWI453207B (zh) * | 2008-09-08 | 2014-09-21 | Signal Pharm Llc | 胺基三唑并吡啶,其組合物及使用其之治療方法 |
EP2343294A1 (en) * | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Substituted triazolopyridines |
US8754226B2 (en) * | 2010-05-17 | 2014-06-17 | Array Biopharma Inc. | Piperidinyl-substituted lactams as GPR119 modulators |
TW201204723A (en) * | 2010-06-22 | 2012-02-01 | Fovea Pharmaceuticals | Heterocyclic compounds, their preparation and their therapeutic application |
SI2699575T1 (sl) * | 2011-04-21 | 2015-10-30 | Bayer Intellectual Property Gmbh | Triazolopiridini |
CN104603136B (zh) * | 2012-07-10 | 2017-06-27 | 拜耳医药股份有限公司 | 制备取代的三唑并吡啶的方法 |
-
2014
- 2014-06-03 CN CN201480043932.2A patent/CN105431435A/zh active Pending
- 2014-06-03 JP JP2016517262A patent/JP2016527193A/ja active Pending
- 2014-06-03 US US14/896,429 patent/US20160264568A1/en not_active Abandoned
- 2014-06-03 EP EP14727536.6A patent/EP3004093A1/en not_active Withdrawn
- 2014-06-03 CA CA2914521A patent/CA2914521A1/en not_active Abandoned
- 2014-06-03 WO PCT/EP2014/061416 patent/WO2014195276A1/en active Application Filing
-
2016
- 2016-09-20 HK HK16111004.3A patent/HK1222849A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP3004093A1 (en) | 2016-04-13 |
CA2914521A1 (en) | 2014-12-11 |
JP2016527193A (ja) | 2016-09-08 |
WO2014195276A1 (en) | 2014-12-11 |
CN105431435A (zh) | 2016-03-23 |
US20160264568A1 (en) | 2016-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1222846A1 (zh) | 取代的苄基吡唑 | |
HK1221717A1 (zh) | 取代的苄基吡唑 | |
HK1223270A1 (zh) | 長效螺異惡唑啉製劑 | |
HK1216531A1 (zh) | 新的抑制劑 | |
HRP20171890T1 (hr) | Supstituirani imidazopiridazini | |
HK1223362A1 (zh) | 取代的吡唑並吡啶胺 | |
EP3030071A4 (en) | GROWING SYSTEM | |
HK1220972A1 (zh) | 取代的噻唑並嘧啶 | |
IL246271A0 (en) | Converted piperidinyl-tetrahydroquinolines | |
GB201320432D0 (en) | Novel formulation | |
IL246230A0 (en) | Amines thf quinazoline as pde1 inhibitors | |
HK1222849A1 (zh) | 具有作爲 抑制劑的活性的取代的三唑並吡啶類 | |
GB201322948D0 (en) | Improved formulation | |
HK1222652A1 (zh) | 取代的三唑並吡啶類 | |
HK1219728A1 (zh) | 新型抗瘧疾藥劑 | |
GB201317718D0 (en) | Novel formulation | |
HK1220486A1 (zh) | 啓動子組合物 | |
GB201311560D0 (en) | Concept twenty-nine | |
GB201317717D0 (en) | Novel formulation | |
GB201307423D0 (en) | Harrow | |
GB201303355D0 (en) | Zippy Doodah |